Kolexia
Leblond Pierre Pédiatrie
Leblond Pierre
Pédiatrie
Centre Léon-Bérard
Lyon, France
200 Activités
25 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Gliome Tumeurs du cerveau Médulloblastome Récidive tumorale locale Astrocytome Épendymome Gliome infiltrant du tronc cérébral Neurofibromatoses Tumeur rhabdoïde

Collaborateurs

Voir plus
Andre Nicolas
Andre Nicolas
Hôpital La Timone Enfants, Marseille, France
Salamon-Bertozzi Anne-Isabelle
Salamon-Bertozzi Anne-Isabelle
Hôpital Paule de Viguier, Toulouse, France
Aerts Isabelle
Aerts Isabelle
Clcc Institut Curie, Paris, France
Frappaz Didier
Frappaz Didier
Centre Léon-Bérard, Lyon, France

Industries

Voir plus
AstraZeneca
2 collaboration(s)
Dernière en 2021
SERB
1 collaboration(s)
Dernière en 2023
Novartis
1 collaboration(s)
Dernière en 2020
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
BIOMEDE 2: Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
Essai Clinique (Chimerix)   29 février 2024
PLGG - MEKTRIC: A Randomized and Controlled Phase II Protocol in Non NF1 Pediatric and AYA (Adolescent and Young Adults) Patients Bearing a Newly Diagnosed Low Grade Glioma With Wild Type BRAF Gene Comparing a Daily Oral MEK Inhibitor (Trametinib) Versus Weekly Vinblastine for 18 Months
Essai Clinique (CHU Strasbourg)   15 février 2024
COTESARC: A Multicentre, Open-label, Phase I-II Study Evaluating the Combination of a MEK Inhibitor and a PDL1 Inhibitor in Pediatric and Adult Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma.
Essai Clinique (Centre Léon-Bérard)   09 février 2024
MEMMAT: A Phase II Study of Metronomic and Targeted Anti-angiogenesis Therapy for Children With Recurrent/Progressive Medulloblastoma, Ependymoma and ATRT
Essai Clinique (Medical University of Vienna)   27 janvier 2024
METRO-PD1: Phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumors.
European journal of cancer (Oxford, England : 1990)   06 janvier 2024
A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation.
Acta neuropathologica   08 décembre 2023
Antiseizure effect of MEK inhibitor in a child with neurofibromatosis type 1-Developmental and epileptic encephalopathy and optic pathway glioma.
Epileptic disorders : international epilepsy journal with videotape   20 novembre 2023
EPID-10. CNSONTRK STUDY: CLINICAL CHARACTERISTICS AND OUTCOME OF CENTRAL NERVOUS SYSTEM TUMORS HARBORING NTRK GENE FUSIONS
Abstracts from the 2023 Society for Neuro-Oncology’s 28th Annual Scientific Meeting and Education Day   10 novembre 2023
ASSESSMENT OF A NOVEL READY-TO-USE TEMOZOLOMIDE ORAL SUSPENSION IN CHILDREN WITH SOLID TUMORS: RESULTS OF TEMOKIDS, A POPULATION PHARMACOKINETIC, ACCEPTABILITY AND SAFETY PHASE-1 STUDY
Abstracts from the 55th Congress of the International Society of Paediatric Oncology (SIOP) October 11–14, 2023   02 novembre 2023
Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial.
JAMA oncology   26 octobre 2023